EUVIMEDEUVIMED entdecken
Open Access

PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience

Ann-Christin Eder, Mohamed A Omrane, Jessica Matthias, Sven Stadlbauer, Mareike Roscher, Kerstin Michalski, Martin A Schick, Christoph-Ferdinand Wielenberg, Peter Bronsert, Christian Gratzke, Martin Freitag, Klaus Kopka und 4 weitere

Theranostics · 05.07.2026 · 16 (14) · 7926-7936

DOI: 10.7150/thno.129889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 05.07.2026. Verfasst von Ann-Christin Eder und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Surgery, Computer-Assisted, Optical Imaging. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographySurgery, Computer-AssistedOptical ImagingHumansMaleGallium RadioisotopesAgedAntigens, SurfaceGlutamate Carboxypeptidase IIMiddle AgedRetrospective StudiesGallium Isotopes

Stichwörter der Autor:innen

PET/CT imagingPSMA-targetingfluorescence-guided surgeryhybrid moleculeprostate cancer

Substanzen

Gallium RadioisotopesAntigens, SurfaceGlutamate Carboxypeptidase IIFOLH1 protein, humanGallium Isotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, Freiburg, Germany and German Cancer Research Center, Heidelberg, Germany.
  • Department of Optical Nanoscopy, Max Planck Institute for Medical Research, Heidelberg, Germany.
  • Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
  • TUD Dresden University of Technology, School of Science, Faculty of Chemistry and Food Chemistry, Dresden, Germany.

Zitieren

APA

Eder, A. C., Omrane, M. A., Matthias, J., Stadlbauer, S., Roscher, M., Michalski, K., Schick, M. A., Wielenberg, C. F., Bronsert, P., Gratzke, C., Freitag, M., Kopka, K., Eder, M., Meyer, P. T., Jilg, C. A., & Ruf, J. (2026). PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience. Theranostics, 16(14), 7926-7936. https://doi.org/10.7150/thno.129889

Vancouver

Eder AC, Omrane MA, Matthias J, Stadlbauer S, Roscher M, Michalski K, et al. PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience. Theranostics. 2026;16(14):7926-7936. doi:10.7150/thno.129889

BibTeX
@article{Eder2026,
  author = {Eder, Ann-Christin and Omrane, Mohamed A and Matthias, Jessica and Stadlbauer, Sven and Roscher, Mareike and Michalski, Kerstin and Schick, Martin A and Wielenberg, Christoph-Ferdinand and Bronsert, Peter and Gratzke, Christian and Freitag, Martin and Kopka, Klaus and Eder, Matthias and Meyer, Philipp T and Jilg, Cordula A and Ruf, Juri},
  title = {PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {14},
  pages = {7926--7936},
  doi = {10.7150/thno.129889}
}
Kostenlos starten →